ACUTE MYELOCYTIC-LEUKEMIA ASSOCIATED WITH THROMBOCYTOSIS AND INV-3(Q21.3,Q26.2) IN A CASE OF GRONBLAND-STRANDBERG SYNDROME

被引：2
|
作者：
TASAKA, T
NAGAI, M
KUBOTA, Y
SASAKI, K
MURATA, M
TAOKA, T
IKEDA, K
TANAKA, T
TAKAHARA, J
IRINO, S
机构：
[1] KAGAWA UNIV,SCH MED,DEPT CLIN LAB,MIKI,KAGAWA 76107,JAPAN
[2] KAGAWA UNIV,SCH MED,DEPT TRANSFUS MED,MIKI,KAGAWA 76107,JAPAN
来源：
LEUKEMIA RESEARCH | 1992年 / 16卷 / 12期
关键词：
ACUTE MYELOCYTIC LEUKEMIA; THROMBOCYTOSIS; INVERSION-3Q; GRONBLAND-STRANDBERG SYNDROME; ELASTIN; CONNECTIVE TISSUE DISORDER;
D O I：
10.1016/0145-2126(92)90117-P
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gronbland-Strandberg syndrome is an inherited connective tissue disorder with cutaneous, opthalomologic, and systemic manifestations. Here we report a case of AML with thrombocytosis arising in a patient with this syndrome. Karyotypic analysis of bone marrow cells revealed the inversion 3 (q21.3;q26.2). To our knowledge, this is the first report of the association of AML with thrombocytosis and Gronbland-Strandberg syndrome. This might be a coincidental association, but it suggests some interesting speculations regarding the pathogenesis of these diseases.
引用
收藏
页码：1187 / 1190
页数：4
相关论文
共 29 条
  • [1] Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols
    Sitges, Marta
    Boluda, Blanca
    Garrido, Ana
    Morgades, Mireia
    Granada, Isabel
    Barragan, Eva
    Arnan, Montserrat
    Serrano, Josefina
    Tormo, Mar
    Miguel Bergua, Juan
    Colorado, Mercedes
    Salamero, Olga
    Esteve, Jordi
    Benavente, Celina
    Perez-Encinas, Manuel
    Coll, Rosa
    Marti-Tutusaus, Josep-Maria
    Brunet, Salut
    Sierra, Jorge
    angel Sanz, Miguel
    Montesinos, Pau
    Ribera, Josep-Maria
    Vives, Susana
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (02) : 138 - 147
  • [2] Lenalidomide Plus Hypomethylating Agent for Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities -AML with Inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, Mecom
    Merz, Lauren E.
    Perissinotti, Anthony J.
    Marini, Bernard Lawrence
    Crouch, Ashley
    Pettit, Kristen
    Burke, Patrick W.
    Erba, Harry P.
    Bixby, Dale L.
    BLOOD, 2018, 132
  • [3] Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM
    Merz, Lauren E.
    Perissinotti, Anthony J.
    Marini, Bernard L.
    Burke, Patrick W.
    Crouch, Ashley
    Erba, Harry P.
    Bixby, Dale
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : 24 - 30
  • [4] Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
    Medeiros, Bruno C.
    Kohrt, Holbrook E.
    Arber, Daniel A.
    Bangs, Charles D.
    Cherry, Athena M.
    Majeti, Ravindra
    Kogel, Karen E.
    Azar, Catherine A.
    Patel, Samit
    Alizadeh, Ash A.
    LEUKEMIA RESEARCH, 2010, 34 (05) : 594 - 597
  • [5] Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality
    Calderon-Cabrera, Cristina
    Falantes, Jose F.
    Bernal, Ricardo
    Perez-Simon, Jose A.
    MEDICINA CLINICA, 2015, 145 (05): : 224 - 226
  • [6] Myelodysplastic Syndrome With inv(3)(q21q26.2) or t(3;3)(q21;q26.2) Has a High Risk for Progression to Acute Myeloid Leukemia
    Cui, Wei
    Sun, Jianlan
    Cotta, Claudiu V.
    Medeiros, L. Jeffrey
    Lin, Pei
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (02) : 282 - 288
  • [7] Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
    Richard-Carpentier, Guillaume
    Rausch, Caitlin R.
    Sasaki, Koji
    Hammond, Danielle
    Morita, Kiyomi
    Takahashi, Koichi
    Tang, Guilin
    Kanagal-Shamanna, Rashmi
    Bhalla, Kapil
    Dinardo, Courtney D.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Shpall, Elizabeth J.
    Alousi, Amin
    Daver, Naval G.
    Garcia-Manero, Guillermo
    Konopleva, Marina Y.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    HAEMATOLOGICA, 2023, 108 (09) : 2331 - 2342
  • [8] Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study
    Gong, Xubo
    Yu, Teng
    Tang, Qiusu
    Fu, Yanbiao
    Wu, Jie
    Zhu, Yongze
    Tu, Hongxiang
    Ge, Haifeng
    Lu, Xingguo
    Gong, Donghua
    Zhao, Xiaoying
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (03) : 380 - 386
  • [9] Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
    Richard-Carpentier, Guillaume
    Rausch, Caitlin R.
    Sasaki, Koji
    Hammond, Danielle
    Morita, Kiyomi
    Takahashi, Koichi
    Tang, Guilin
    Kanagal-Shamanna, Rashmi
    Bhalla, Kapil
    Dinardo, Courtney D.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Shpall, Elizabeth J.
    Alousi, Amin
    Daver, Naval G.
    Garcia-Manero, Guillermo
    Konopleva, Marina Y.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    REVISTA CHILENA DE LITERATURA, 2023, (108): : 2331 - 2342
  • [10] OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA HARBORING INV(3)/(Q21;Q26.2)/T(3;3)(Q21;Q26.2)
    Aoki, J.
    Ishiyama, K.
    Uchida, N.
    Fukuda, T.
    Ohashi, K.
    Hidaka, M.
    Kobayashi, N.
    Sakura, T.
    Aotsuka, N.
    Okumura, H.
    Ichinohe, T.
    Tanaka, J.
    Atsuta, Y.
    Yano, S.
    HAEMATOLOGICA, 2017, 102 : 620 - 621
123